Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: disease

  • Exercise Intervention for Improving Metabolic-Associated Fatty Liver Disease

    Researchers assessed the histological appearance of liver biopsies from patients with metabolic-associated fatty liver disease (MAFLD) who completed 12 weeks of structured and supported aerobic exercise. Compared to biopsies from a nonexercising control group, the intervention arm demonstrated some reversal of histopathologic changes caused by MAFLD.

  • Phospho-Tau217 Blood Biomarker May Help to Diagnose Early Alzheimer’s Disease

    Serum phospho-tau217, a biomarker of tau protein that can be detected in the blood, is increased in preclinical Alzheimer’s disease and may have clinical utility for the early detection of brain pathology.

  • The Perks of Palliative Care

    Most healthcare providers know that compassionate care and honest conversations with patients can lead to trusting relationships and better outcomes. Those relationships are even more important as a patient edges toward the end of life, or received a diagnosis of chronic or terminal illness. This is where palliative care comes in.

  • Neurotropism of COVID-19: What Is New?

    SARS-CoV-2 may gain access to the brain via the olfactory epithelium. The olfactory epithelium and bulbs may serve as an entry point for SARS-CoV-2 infection into the central nervous system.

  • Childhood Diseases Associated with Antibiotic Exposure During Infancy

    A population-based cohort study showed that exposure to antibiotics during the first two years of life is associated with increased rates of subsequently developing asthma, allergic rhinitis, atopic dermatitis, attention deficit hyperactivity disorder, celiac disease, and obesity.

  • FDA Approves Pfizer Vaccine for COVID-19

    The Food and Drug Administration’s vaccine advisory committee has approved the use of the COVID-19 vaccine developed by Pfizer Inc. (NYC) and BioNTech (Mainz, DEU) in the United States for those ages 16 years and older. The first doses will go to healthcare workers and long-term care residents.

  • With Political Change, OSHA Infectious Disease Standard Appears Back in Play

    In acknowledged underestimates, the Centers for Disease Control and Prevention reports tens of thousands of healthcare workers have acquired COVID-19 and hundreds have died. With CDC guidelines nonregulatory, politicized, and too often ignored during the pandemic, the question arises: Could an enforceable infectious disease standard by the Occupational Safety and Health Administration have saved lives during the pandemic?

  • Occupational COVID-19 Exposures to Colleagues

    Healthcare workers may be vigilant with personal protective equipment around COVID-19 patients, but inadvertently expose themselves to colleagues when they take breaks, socialize, and eat. Part of the problem is healthcare workers are experiencing PPE fatigue and may be tempted to removed gear for brief respites when possible.

  • Nutritional Interventions in Prodromal Alzheimer’s Disease: The 36-Month LipiDiDiet Multinutrient Clinical Trial

    In a randomized, double-blind, placebo-controlled trial of Fortasyn Connect (Souvenaid), a nutraceutical drink, patients with prodromal Alzheimer’s disease demonstrated, over a 36-month period, a slower decline in cognitive functions compared to the control group.

  • Multiple Sclerosis and Vascular Disease

    This postmortem study of multiple sclerosis (MS) patients evaluated the presence and pathological significance of extracranial systemic and cerebral small vessel disease in patients with MS compared to healthy controls. MS patients had less systemic vascular disease and more small vessel disease in the brain compared to controls.